Jalupro Super Hydro (Jalupro Hydro)

Jalupro

Injectable Skin Booster

Biorevitalising Hyaluronic Acid & Amino Acid Injectable

CE Marked Class III medical device (EU medical device safety standard) for injectable use in aesthetic medicine
Intended for professional use in accordance with applicable national regulations on medical devices and injectable aesthetic treatments

CE Marked Class III medical device (EU medical device safety standard) for injectable use in aesthetic medicine
Intended for professional use in accordance with applicable national regulations on medical devices and injectable aesthetic treatments

Biorevitalising Hyaluronic Acid & Amino Acid Injectable

Description

Jalupro Super Hydro (often referred to as Jalupro Hydro) is a sterile, reabsorbable injectable skin booster designed for deep biorevitalisation and bio-remodelling of the face and body. It combines a high total dose of non-crosslinked hyaluronic acid with a specific cluster of amino acids and three biomimetic peptides to intensely hydrate the skin, stimulate fibroblasts, support facial ligaments and improve overall skin structure. Indicated for sagging, photo-aged, dehydrated and dull skin, it targets both superficial dermis and deeper connective tissues to restore elasticity, firmness and radiance.

Bnefits

Deep and long-lasting skin hydration via a blend of low and high molecular weight hyaluronic acid
Biorevitalisation and bio-remodelling of dermis and retaining ligaments for structural support
Stimulation of collagen and elastin synthesis through targeted amino acid cluster and peptides
Improvement in skin elasticity, firmness and density with visible lifting effect
Reduction in fine lines, wrinkles and signs of photo-ageing
Enhanced skin texture, tone and radiance for a more youthful appearance
Support of extracellular matrix and ligament regeneration, helping to counteract sagging
Suitable for multiple areas including face, neck, décolletage, hands and selected body zones

Indications

Photo-aging and chrono-aging of the face and body (moderate to severe)
Loss of skin elasticity, tone and firmness
Dry, dehydrated or dull skin
Sagging tissues and loss of definition of facial contours
Dermal atrophy and early to advanced signs of ageing
Skin quality improvement (texture irregularities, fine lines, roughness)
Support and bio-restoration of facial ligaments and deep connective tissues
Adjunctive treatment before or after aesthetic procedures such as peels, laser, RF, microneedling or fillers
Treatment areas: face, peri-orbital region (with appropriate technique), neck, décolletage, hands, inner thighs, knees and selected body areas as per professional judgement

Composition

Hyaluronic acid 80 mg / 2.5 ml total (non-crosslinked blend of low molecular weight ~200 kDa and high molecular weight ~2000 kDa, approx. 3.2% HA solution)
Amino acids (7): Glycine, L-Proline, L-Lysine, L-Leucine, L-Alanine, L-Valine, L-Arginine
Biomimetic peptides (3): Acetyl Decapeptide-3, Oligopeptide-24, Acetyl Tetrapeptide-5
Additional excipients: mannitol, sodium chloride, phosphate buffer and purified water (exact excipient list may vary slightly by market presentation)

Formulation

Sterile, pyrogen-free, non-crosslinked hyaluronic acid solution
Blend of low and high molecular weight hyaluronic acid for both hydration and scaffolding
Amino Acid Replacement Therapy (ART) concept: targeted amino acid cluster to provide collagen precursors
Biomimetic peptide complex to stimulate fibroblasts, support ligament regeneration and reduce glycation
Ready-to-use injectable gel for intradermal and subdermal administration by healthcare professionals only

Packaging

Medical device, Class III (EU) injectable skin booster
1 x 2.5 ml pre-filled, sterile, single-use syringe
Blister-packed unit intended for professional use only
Typically supplied without needles; 27–30G needles or suitable cannulas recommended according to treatment protocol
Outer carton with package insert including instructions for use, indications and safety information

Usage

For strict medical use only; administration by trained and authorised healthcare professionals experienced in injectable treatments.
Administer via intradermal or subdermal injections, commonly using 27–30G needles, following manufacturer-recommended facial ligament or skin booster injection patterns.
Typical protocol: 0.2 ml boluses at strategic points (e.g. 6+1 points over main facial retaining ligaments) or distributed micro-injections across the treatment area as per clinical judgement.
Common treatment schedule: 2–4 sessions spaced approximately 3–4 weeks apart, with maintenance sessions every 6–12 months depending on patient response, age and skin condition.
Do not inject into blood vessels; aspirate and follow safe injection techniques to minimise risk of intravascular injection.
Avoid use on or near areas with active infection, inflammation, or damaged skin.
After treatment, advise patients to avoid intense heat (saunas, sunbeds), strenuous exercise, alcohol excess and makeup on treated areas for 24 hours or as clinically appropriate.
Post-treatment care typically includes gentle skin care, strict photoprotection with broad-spectrum sunscreen and avoidance of direct sun exposure for 24–48 hours.
Single-use only; any unused product must be discarded and not reused or re-sterilised.

Contraindications

Hypersensitivity or allergy to hyaluronic acid, amino acids, peptides, mannitol, lidocaine (if present in specific market formulation) or any other component of the product
Active skin infection, inflammation or dermatologic disease at or near the intended injection site (e.g. herpes simplex, bacterial or fungal infections)
History of severe allergies, anaphylactic reactions or known severe autoimmune disease, unless carefully evaluated by a specialist
Pregnancy and breastfeeding (use is generally not recommended due to lack of safety data)
Known bleeding disorders, current anticoagulant therapy or uncontrolled systemic disease where injections may pose additional risk
Previous hypersensitivity reactions to injectable skin boosters or similar biorevitalising products
Patients with unrealistic expectations or unsuitable psychological profile for aesthetic injectable treatments

Adverse Effects

Common, usually transient: redness (erythema), mild to moderate swelling, tenderness, itching, pain or warmth at injection sites
Possible: small papules, bruising, ecchymosis or haematoma at injection points
Less common: local infection, prolonged oedema, nodules or palpable irregularities requiring medical management
Rare but serious: hypersensitivity reactions, granuloma formation, vascular compromise if inadvertently injected intravascularly; requires immediate medical attention
As with all injectable procedures, adverse events are generally reduced by correct technique, strict asepsis and appropriate patient selection

Storage Conditions

Store at 2–25°C (36–77°F) in a cool, dry place.
Protect from direct sunlight and sources of heat.
Do not freeze.
Keep in original packaging until use to maintain sterility and protect from light.
Use immediately after opening the syringe; any unused remainder must be discarded.

Duration

Initial visible hydration and plumping are often noticeable immediately, with progressive improvements in firmness and texture over several weeks. Clinical sources commonly report results lasting approximately 6\u201312 months, depending on factors such as age, skin condition, lifestyle and treatment protocol, with maintenance sessions recommended to sustain the effect.

Onset

Immediate improvement in hydration and skin plumpness following injection, with further enhancement of collagen and elastin production developing gradually over the subsequent weeks.